My Web Dashboard





SEO News: ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus (FinanzNachrichten)

SEATTLE and GENEVA, Nov. 13 /PRNewswire-FirstCall/ -- ZymoGenetics, ( Nachrichten ) Inc. and Serono ( Nachrichten / Aktienkurs ) (virt-x: SEO and NYSE: SRA) today presented positive results at the American College of Rheumatology (ACR) annual meeting from a Phase 1b study in systemic lupus erythematosus (SLE) patients treated with atacicept(1). The results showed that atacicept was well tolerated

read more...

Related News